Skip to main content
. 2021 Nov 2;13(21):5507. doi: 10.3390/cancers13215507

Table 4.

Acute and late adverse events for all patients.

Variation Grade 2 (%) Grade 3 (%) Grade 4 (%)
Acute adverse event
Mucositis 18 (41) 5 (11) 0 (0)
Dermatitis 11 (25) 0 (0) 0 (0)
Dysgeusia 3 (7) 0 (0) 0 (0)
Dry mouth 1 (2) 0 (0) 0 (0)
Dysphagia 1 (2) 0 (0) 0 (0)
Late adverse event
Dry mouth 1 (2) 0 (0) 0 (0)
Trismus 1 (2) 0 (0) 0 (0)
Retinopathy 1 (2) 0 (0) 0 (0)
Oral hemorrhage 1 (2) 0 (0) 0 (0)
Keratitis 0 (0) 1 (2) 0 (0)